Industry News
New Policies Aimed At Controlling Costs Should Not Follow 'One Size Fits All' Approach
Apr 11, 2012
In the current hyper-charged United States healthcare debate, the focus on lowering cost without compromising quality of care remains a priority. But according to a new study by researchers at NYU Langone Medical Center and colleagues, one common approach may have serious unintended consequences... Read More
Link Between 2 Genetic Deletions In Human Genome And The Development Of Aggressive Prostate Cancer
Apr 11, 2012
An international research team led by Weill Cornell Medical College investigators have discovered two inherited-genetic deletions in the human genome linked to development of aggressive prostate cancer... Read More
Dental X Rays Tied To Brain Tumors
Apr 11, 2012
The largest study of its kind finds that a history of frequent dental x-rays, particularly at a young age, is tied to an increased risk of developing meningioma, the most common type of primary brain tumor in the United States... Read More
Major Source Of Cells' Defense Against Oxidative Stress Identified
Apr 11, 2012
Both radiation and many forms of chemotherapy try to kill tumors by causing oxidative stress in cancer cells. New research from USC on a protein that protects cancer and other cells from these stresses could one day help doctors to break down cancer cells' defenses, making them more susceptible to treatment. In the Journal of Biological Chemistry, scientists led by USC Professor Kelvin J. A... Read More
Critical Genes Mutated In Stomach Cancer Identified
Apr 11, 2012
An international team of scientists, led by researchers from the Duke-NUS Graduate Medical School (Duke-NUS) in Singapore and National Cancer Centre of Singapore, has identified hundreds of novel genes that are mutated in stomach cancer, the second-most lethal cancer worldwide... Read More
Fractionated Gemtuzumab Ozogamicin Dosing Regimen Improves Outcomes For Some Leukemia Patients
Apr 10, 2012
A French study published Online First in The Lancet has revealed that fractionizing the dosage of the targeted anticancer drug gemtuzumab ozogamicin allows for safer delivery of the drug into patients between the ages of 50 to 70 years with acute myeloid leukemia (AML) and significantly improves their outcomes... Read More
Tiny Wireless Device Powers Itself Through Bloodstream
Apr 10, 2012
Engineers at Stanford University have demonstrated how a tiny, externally controlled, wirelessly-powered medical device, is able to propel itself through blood, in a manner reminiscent of the 1966 film Fantastic Voyage, where a microscopic submarine and scientific crew are injected into the bloodstream of a man... Read More
News From The Journal Of Clinical Investigation: April 9, 2012
Apr 10, 2012
ONCOLOGY Harnessing the power of angiogenesis inhibitors The development of new blood vessels, known as angiogenesis, is critical for processes such as wound healing, but is exploited by tumors to enable more robust growth... Read More
Gold Nanostars First To Deliver Drug Directly To Cancer Cell Nucleus
Apr 10, 2012
Nanotechnology offers powerful new possibilities for targeted cancer therapies, but the design challenges are many. Northwestern University scientists now are the first to develop a simple but specialized nanoparticle that can deliver a drug directly to a cancer cell's nucleus -- an important feature for effective treatment... Read More
Cancer Diagnosis And Risk Of Suicide And Fatal Heart Attack
Apr 10, 2012
People who are diagnosed with cancer have a markedly increased risk of suicide and cardiovascular death during the period immediately after being given the diagnosis. This has been shown in a new study from Karolinska Institutet, published in the prestigious scientific journal the New England Journal of Medicine... Read More
Previous Page Next Page